These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35410394)

  • 1. In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common "diuretic and masking agent" in doping.
    Busardò FP; Lo Faro AF; Sirignano A; Giorgetti R; Carlier J
    Arch Toxicol; 2022 Jul; 96(7):1989-2001. PubMed ID: 35410394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.
    Harrison MF; Anderson PJ; Johnson JB; Richert M; Miller AD; Johnson BD
    PLoS One; 2016; 11(2):e0148206. PubMed ID: 26848757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibition delays plasma lactate appearance with no effect on ventilatory threshold.
    Scheuermann BW; Kowalchuk JM; Paterson DH; Cunningham DA
    J Appl Physiol (1985); 2000 Feb; 88(2):713-21. PubMed ID: 10658042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives.
    Lo Faro AF; Tini A; Bambagiotti G; Pirani F; Faragalli A; Carle F; Pacella E; Ceka A; Moretti M; Gottardi M; Lassandro NV; Nicolai M; Lupidi M; Mariotti C; Busardò FP; Carlier J
    Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body water and electrolyte responses to acetazolamide in humans.
    Brechue WF; Stager JM; Lukaski HC
    J Appl Physiol (1985); 1990 Oct; 69(4):1397-401. PubMed ID: 2262460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a fast ultra-high-performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair.
    Lo Faro AF; Tini A; Gottardi M; Pirani F; Sirignano A; Giorgetti R; Busardò FP
    Drug Test Anal; 2021 Aug; 13(8):1552-1560. PubMed ID: 33908166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme inhibition coupled to molecularly imprinted polymers for acetazolamide determination in biological samples.
    Elfadil D; Palmieri S; Della Pelle F; Sergi M; Amine A; Compagnone D
    Talanta; 2022 Apr; 240():123195. PubMed ID: 34990987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.
    Fan JL; Burgess KR; Thomas KN; Lucas SJ; Cotter JD; Kayser B; Peebles KC; Ainslie PN
    J Physiol; 2012 Mar; 590(5):1213-25. PubMed ID: 22219343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle metabolism during heavy-intensity exercise after acute acetazolamide administration.
    Scheuermann BW; Kowalchuk JM; Paterson DH; Taylor AW; Green HJ
    J Appl Physiol (1985); 2000 Feb; 88(2):722-9. PubMed ID: 10658043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent.
    Taoussi O; Gameli PS; Berardinelli D; Busardò FP; Tini A; Carlier J
    J Pharm Biomed Anal; 2024 Jan; 238():115759. PubMed ID: 37866082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs.
    Höhne C; Krebs MO; Seiferheld M; Boemke W; Kaczmarczyk G; Swenson ER
    J Appl Physiol (1985); 2004 Aug; 97(2):515-21. PubMed ID: 15247196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal circulatory effects of acetazolamide in patients with essential hypertension.
    Horita Y; Yakabe K; Tadokoro M; Suyama N; Hayashida K; Kawano Y; Miyazaki M; Kohno S; Taura K
    Am J Hypertens; 2006 Mar; 19(3):282-5. PubMed ID: 16500514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderate-intensity exercise.
    Scheuermann BW; Kowalchuk JM; Paterson DH; Cunningham DA
    J Appl Physiol (1985); 1999 May; 86(5):1544-51. PubMed ID: 10233116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetazolamide on respiratory muscle fatigue in humans.
    Gonzales JU; Scheuermann BW
    Respir Physiol Neurobiol; 2013 Jan; 185(2):386-92. PubMed ID: 23017330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide.
    Dahl A; Russell D; Rootwelt K; Nyberg-Hansen R; Kerty E
    Stroke; 1995 Dec; 26(12):2302-6. PubMed ID: 7491655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetazolamide affects breathing differently in ICR and C57 mice.
    Schlenker E; Shi Y; Johnson C; Wipf J
    Respir Physiol Neurobiol; 2006 Jun; 152(2):119-27. PubMed ID: 16140042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions.
    Garske LA; Brown MG; Morrison SC
    J Appl Physiol (1985); 2003 Mar; 94(3):991-6. PubMed ID: 12391068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide reduces peripheral afferent transmission in humans.
    Brechue WF; Koceja DM; Stager JM
    Muscle Nerve; 1997 Dec; 20(12):1541-8. PubMed ID: 9390667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting carbonic anhydrase in brain tissue increases the respiratory response to rebreathing CO2.
    Adams JM; Johnson NL
    Brain Res; 1990 Jun; 519(1-2):23-8. PubMed ID: 2118820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acetazolamide on gas exchange and acid-base control after maximal exercise.
    Kowalchuk JM; Heigenhauser GJ; Sutton JR; Jones NL
    J Appl Physiol (1985); 1992 Jan; 72(1):278-87. PubMed ID: 1537726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.